Pharmafit Provence
HYLO CONFORT S ophtalm hydratante Fl/10ml
Ursapharm

HYLO CONFORT S ophtalm hydratante Fl/10ml

VIDAL information
Your professional account

PharmaFit supplies pharmacies and healthcare professionals. Access your purchasing terms and availability through your professional account.

Access is reserved for authorised professionals, following account approval.

Contact PharmaFit

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Parapharmacy
Update of 10/09/2026

CE HYLO CONFORT
sodium hyaluronate ophthalmic solution at 0,1 %

Forms and presentations 

Sterile solution, without phosphate and without preservatives for ophthalmic use:  Multidose bottle of 10 ml of eye drops in solution (ACL 3401040669122).

Composition 

1 ml of Hylo Confort contains 1 mg of sodium hyaluronate, anhydrous citric acid, sodium citrate, sorbitol and water for injectable preparations.

PROPERTIES and USE 

Hylo Confort is intended to improve hydration of the surface of the eye in cases of environmentally caused disorders such as dry eye, foreign body or burning sensations, as well as after ophthalmic surgery.

Hylo Confort is compatible with wearing contact lenses.

Based on current scientific knowledge, Hylo Confort can be used without any particular precautions in children as well as in pregnant and breastfeeding women.

Directions for use 

Instil 1 drop of Hylo Confort 3 times a day into the conjunctival sac of each eye.

Precautions for use 

Use Hylo Confort only if the outer packaging is intact and sealed before first use.

After use, immediately and carefully replace the cap on the dropper tip. Ensure the dropper tip is dry. Avoid any contact between the dropper tip and the eye or facial skin during instillation.

In case of concomitant treatment with another eye drop, an interval of at least 30 minutes must be observed between the two applications. Hylo Confort must always be instilled last. However, an eye ointment must always be applied into the conjunctival sac after Hylo Confort. Thanks to the absence of preservatives, Hylo Confort is particularly well tolerated, even with prolonged use.

To avoid intolerance reactions that may be caused by interactions between Hylo Confort and contact lens care products, it is advised to wait approximately 30 minutes after inserting contact lenses before instilling the eye drops.

Hylo Confort must not be used in case of hypersensitivity to any of the components.

Store at a temperature not exceeding 25 °C.

Hylo Confort is stored for 6 months after opening.

Do not use after the expiry date.

Keep out of the reach and sight of children.

Possible undesirable effects:
In very rare cases, reactions such as hypersensitivity, a burning sensation or tearing, pain, a foreign body sensation or other temporary local irritation have been reported and disappeared immediately after discontinuing use of Hylo Confort.
Due to the viscosity of the preparation, temporary blurred vision is possible just after using Hylo Confort. In very rare cases, this may cause temporary headaches in sensitive patients.

ADMINISTRATIVE INFORMATION 

LPPR rate: 7,48 euros (LPPR code 1165660).
Public price:9,41 euros.
 
Covered indication:
Symptomatic treatment of dry eye with keratitis or dry keratoconjunctivitis as third-line therapy after failure of low-viscosity artificial tear substitutes and gels (carbomer types).
 
Prescribing and use conditions:
- Prescription by an ophthalmologist after diagnosis of keratitis or dry keratoconjunctivitis, in particular by a colorimetric test performed with the slit lamp.
- Initial prescription must not exceed 6 months of treatment. At the end of this period, reassessment ideally by an ophthalmologist for a possible renewal of the prescription.

Medical device. Class II a.
Manufacturer: Ursapharm GmbH D - 66129 Saarbrücken, Germany.

Laboratoires URSAPHARM SAS
7, rue Denis-Papin
57200 Sarreguemines
Tel: 03 87 02 06 08. Fax: 03 87 09 77 90.
E-mail: info@ursapharm.fr
Website: www.ursapharm.fr

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.